Ashford Capital reports 5.57% stake in ReposiTrak
ReposiTrak, Inc. Schedule 13G filed by Ashford Capital Management, Inc. reports beneficial ownership of 1,014,028 shares of common stock, representing 5.57% of the class based on February 17, 2026 outstanding share count.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ReposiTrak, Inc. Schedule 13G filed by Ashford Capital Management, Inc. reports beneficial ownership of 1,014,028 shares of common stock, representing 5.57% of the class based on February 17, 2026 outstanding share count. The filing states these shares are held across separate client accounts, three limited partnerships, and one commingled fund.
Insights
Institutional holder discloses a 5.57% stake across client accounts and pooled vehicles.
Ashford Capital Management reports 1,014,028 shares with sole voting and dispositive power over those shares. The percentage is calculated using the issuer's reported 18,203,410 shares outstanding as of February 17, 2026.
Holder concentration is meaningful for registry purposes but below common 10% materiality thresholds; subsequent filings could show changes if accounts or fund allocations shift.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership regulatory
Sole dispositive power regulatory
Commingled fund financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Ashford Capital hold in ReposiTrak (TRAK)?
How is Ashford Capital's reported ownership held?
Who signed the Schedule 13G for Ashford Capital?
AI-generated analysis. How Rhea-AI works. Not financial advice.